Objective: The objective of this study is to establish the magnitude change and interreader reliability of the liver standardized uptake value corrected for lean body mass (SUL mean ) in dual-time-point imaging at 1 and 2 hours and 1 and 4 hours. Patients and Methods: Early and delayed FDG PET/CT scans were included for 28 patients (13 men and 15 women) who had normal liver by CT or ultrasound. The average uptake time between the early and delayed scans were 55 minutes (range, 44Y69 minutes) for pancreatic adenocarcinoma patients (n = 19) and 184 minutes (range, 140Y197 minutes) for neurofibromatosis patients (n = 9). A 30-mm-diameter spherical volume of interest was placed within the right lobe of the liver above, below, and at the level of the main portal vein by 2 independent readers. Correlation coefficients, analysis of variance, intraclass correlation coefficient, and Bland-Altman analysis were performed. Results: The mean liver SUL mean was between 1.39 and 1.42 and between 1.28 and 1.3 in early and delayed images, respectively (P = 0.001). There is time-dependent reduction in the mean liver SUL mean at 2-hour (7%Y8%) and 4-hour uptake time (15%Y21%) compared with 1-hour uptake time. The correlation coefficient between delayed uptake time and liver SUL mean reduction is 0.39 to 0.41 at the upper aspect of the liver. The intraclass correlation coefficient for 2 readers varied between 0.997 and 0.998 and between 0.995 and 0.999 in early and delayed images, respectively (P = 0.001).
T he FDG activity in the liver has been used both qualitatively and quantitatively as a standard in PET/CT imaging in oncology. 1 The liver SUV mean normalized to lean body mass standardized uptake value corrected for lean body mass [SUL mean ] has been proposed as a quality measure for FDG PET/CT and was used in the PET Response Criteria in Solid Tumors 1.0. 2 The SUL mean of the liver is usually measured by placing a spherical volume of interest (VOI) in the right lobe of the liver. The liver SUV mean has also been used as a normalization factor in PET-derived quantitative therapy response formulations, which were further adapted to assess residual disease in colorectal malignancy. 3, 4 In our previous work, 5 we demonstrated that liver SUL mean has almost perfect interreader reliability, regardless of whether the VOI is placed at the upper, lower, or portal vein level of the right lobe of the liver, and the interreader variability is least in the upper aspect of the right lobe of the liver.
FDG PET/CT is a valuable imaging study in the management of many human solid tumors. 6Y11 Dual-time-point and delayed FDG PET imaging may allow for distinction between malignant and benign processes, as the pattern and rate of FDG uptake over time may vary considerably between these 2 processes. 12Y16 In patients with head and neck malignant tumors, 17 pulmonary nodules, 15, 18 breast cancer, 19 pancreatic tumors, 20 and skeletal tumor, 21 several authors have reported significant improvement in the diagnostic accuracy of FDG PET with dual-time-point scans. The time from tracer injection to the time of PET scanning (uptake period) has been shown to have an effect on lesion SUV. 22, 23 The FDG uptake time can vary because of workflow issues in a clinical practice.
The magnitude change of liver SUL mean due to variable uptake time in the same patient has not been established. The reader reliability of measuring liver SUL mean on delayed scans is also not known. Hence, the objectives of this study are to establish the magnitude change of liver SUL mean in dual-time-point imaging at 1 and 2 hours and 1 and 4 hours and to establish interreader reliability of dual or delayed uptake time on liver SUL mean .
PATIENTS AND METHODS
Institutional review board approval was obtained for this Health Insurance Portability and Accountability ActVcompliant retrospective review of FDG PET/CT images and patient records. Informed consent requirements were waived. Patients who previously underwent clinical studies with early and delayed FDG PET/CT scan at our institution were identified between February 2010 and June 2012. Patients who had undergone previous systemic or local therapy or who had any structural hepatic lesions, including hepatic cysts or fatty infiltration seen on CT or ultrasound, within 3 months of baseline PET/CT were excluded to establish a cohort of patients with normal livers.
A total of 28 patients (13 men and 15 women) with biochemical and morphological normal liver were found eligible and included in the study. Of these, 19 were pancreatic adenocarcinoma patients with 1-hour and 2-hour delayed PET/CT scans, and 9 represented neurofibromatosis (NF) type 1 patients with 1-hour and 4-hour delayed PET/CT imaging. In pancreatic patients, the average postinjection time was 64 minutes (T5; range, 56Y73 minutes) on early scans and 118 minutes (T6; range, 109Y129 minutes) on the delayed scans, with an average time between the scans of 55 minutes (T8; range, 44Y69 minutes). For the NF patients, the average postinjection time was 68 minutes (T8; range, 57Y79 minutes) on the early scans and 253 minutes (T21; range, 225Y286 minutes) on the delayed scans, with an average time between the scans of 184 minutes (T18; range, 140Y197 minutes).
PET/CT Protocol
All patients fasted for at least 4 hours before FDG dosing, with a serum glucose level lower than 215 mg/dL and mean of 116 mg/dL (range, 86Y193 mg/dL). 18 F-FDG was administered according to a weight-based formula 9.62 MBq/kg (0.26 mCi/kg). The mean amount of administered FDG was 579.8 T 132.1 MBq ranged 384.8 to 891.7 MBq (15.7 T 3.6 mCi; range, 10.4Y24.1 mCi). For the early PET/CT imaging, a whole-body protocol was used, extending from the base of skull to the midthighs. After the initial PET/CT imaging study was completed, the patients remained in the nuclear medicine department for the second acquisition. For the pancreatic tumors, the delayed scans were performed from the dome of the liver to the lower level of the kidneys. In the NF patients, a delayed whole-body scan was completed at approximately 4 hours after FDG injection.
Twenty-eight patients were scanned on a GE Discovery VCT (General Electric Medical Systems, Waukesha, Wis) 64-slice PET/CT scanner. Both early and delayed images were performed in 3-dimensional acquisition mode with 4.25 minutes per bed position. The images were reconstructed using ordered subset expectation maximization algorithm, with 128 Â 128 matrix, 2 iterations, 21 subsets, 3-mm postreconstruction gaussian filter, standard Z filter, 4.7-mm pixel, and 3.27-mm slice thickness.
All PET data were reconstructed with and without CT-based attenuation correction. Noncontrast CT scan was used for attenuation correction of PET images and for morphologic coregistration. CT parameters were 50-cm axial FOV, 512 Â 512 matrix, weightbased amperage (20Y200 automated mA), 120 kVp, 3.75-mm reconstructed slice thickness, pitch of 0.984, and 0.5-second gantry rotation speed.
Liver SUL mean Measurements
All FDG PET/CT scans were independently interpreted on a MIMvista workstation (software version 5.2; MIM Software Inc, Cleveland, Ohio) by 2 readers, who are both board-certified nuclear medicine physicians. PET, CT, and fused PET/CT images were reviewed in the axial, coronal, and sagittal planes. Liver SUL mean values were measured in the following 3 separate areas within the right lobe of the liver: (a) the right lobe above the portal vein (segments VII and VIII), (b) below the level of the portal vein in the right lower lobe (segments V and VI), and (c) at the level of the right portal vein (straddling segments V through VIII) ( Fig. 1 ). Spherical 30-mmdiameter VOIs were placed at these 3 locations based on the CT and cross-referenced with the PET to assure that the VOIs were within the metabolic boundaries of the right liver. The right lobe of the liver was used because it is easier to draw the region of interest at different levels, giving its larger size, and it is the most common site used in clinical practice. 16, 20, 24, 25 
Statistical Analysis
In-between group analysis for 2 groups was performed with an independent t test with a significance level of 0.05. For repeated measures analyses, adjustment for multiple hypothesis testing comparing the 3 locations within the right lobe of the liver was performed with an analysis of variance with repeated measures, using general linear model, polynomial contrast, and Bonferroni post hoc analysis between all pairs with adjustments (95% confidence interval [CI]; significance level, 0.05). We present our summary statistics as mean T SD for continuous variables or as frequencies and percentages for categorical variables. Variability of the liver SUL mean measurement for the study population was determined with the coefficient of variation at different levels of the right lobe of the liver. The reliability of liver SUL mean measurements between the readers and between the dual-time-point PET images was tested using the intraclass correlation coefficient (ICC) generated by a 2-way random-effects model with an absolute agreement definition (type A), reported as a point estimate with a 95% CI. The independent variable was the patient, and the dependent variable was the readers' liver SUL mean measurement. The placement of the VOI (within the right lobe of the liver) was considered fixed. The absolute agreement definition considers systematic differences between the 2 readers relevant in estimating the ICC. The ICC ranges between 0 and 1.00, with values closer to 1.00 representing better reproducibility. The ICC is interpreted as follows: an ICC of 0.00 to 0.20 indicates slight reproducibility; an ICC of 0.21 to 0.40, fair reproducibility; an ICC of 0.41 to 0.60, moderate reproducibility; an ICC of 0.61 to 0.80, substantial reproducibility; and an ICC of greater than 0.80, almost perfect reproducibility. 15 The agreement between the readers' measurements was evaluated with Bland-Altman analysis reporting the bias (average of all the differences between pairs of measurements), SD, and the 95% limits of agreement (average measurement T 1.96 Â SD). Precision was calculated as 95% CI width divided by 2 and was expressed as percentage multiplying by 100. The agreement was evaluated between readers at each level (the upper, lower, and portal vein levels of the right lobe of the liver). The Pearson correlation coefficients between the elapsed time (early and delayed scans) and the percentage reduction (baseline j delayed/baseline Â 100%) of liver SUL mean were established. We used the Prism 5 (GraphPad Software, San Diego, Calif ) and SPSS 20 (SPSS, Chicago, Ill) statistical packages for all analyses.
RESULTS

Patient Demographics
A total of 28 patients were included in the study, 13 men (46.5%) (mean age, 58.7 T 16.8 years; range, 28Y78 years) and 15 women (53.5%) (mean age, 50.2 T 20.3 years; range, 19Y72 years). The baseline FDG PET/CT scans were performed for the staging of pancreatic cancer (n = 19; mean age, 66 years; range, 48Y78 years) and NF (n = 9; mean age, 39 years; range, 19Y73 years).
Impact of Duration of Delay and Liver SUL mean
For the pancreatic oncologic patients (average uptake time between early and delayed scans of 55 minutes), the average SUL mean change was between 7% and 8%, whereas for the NF type 1 patients (average time between early and delayed scans of 184 minutes), the average SUL mean change was between 15% to 21% ( Table 1 and Fig. 2) . The correlation coefficients between the uptake time and the liver SUL mean at the upper aspect of the right lobe of the liver are r 2 = 0.3991 for reader 1 and r 2 = 0.4186 for reader 2 (Fig. 3) . The absolute change from early to delayed scans of upper level liver SUL mean in the pancreatic oncologic patients was 0.10 (SD, 0.06; range, j0.01 to 0.19) for reader 1 and 0.10 (SD, 0.06; range, 0.01Y0.23) for reader 2 at an uptake time of about 2 hours. For the NF patients, the absolute change in the same upper level was 0.22 (SD, 0.09; range, 0.10Y0.36) for reader 1 and 0.23 (SD, 0.11; range, 0.07Y0.45) for reader 2.
Interreader Agreement and Variability for Liver SUL mean and Placement of VOI: Effect of Early and Delayed Scans
We investigated the reliability of the liver SUL mean as measured by 2 independent readers at 3 levels within the right lobe of the liver in both early and delayed scans. The average measurements made by the 2 readers are summarized in Table 2 . There was excellent agreement between readers for each 1 of the 3 levels in both early and delayed images with the ICC (Table 3 ). These results suggest that the interreader reliability is almost perfect for measuring liver SUL mean in early and delayed FDG PET/CT.
On Bland-Altman analysis, bias were j0.001 (SD, 0.03), j0.013 (SD, 0.03), and j0.012 (SD, 0.03) at the upper, lower, and portal vein level for early images (Fig. 4) . On delayed images, bias were 0.004 (SD, 0.04), j0.001 (SD, 0.03), and j0.022 (SD, 0.05) at upper, lower, and portal vein level, respectively ( Figs. 4 and 5) . These results suggest the variability is minimal between the readers in both early and delayed images.
DISCUSSION
The purpose of our study was to establish the magnitude of change in liver SUL mean due to dual-time imaging or delayed imaging and also to investigate the agreement and variability in measuring liver SUL mean on early and delayed images in dual-point FDG PET/CT. In this study, we have demonstrated that the liver SUL mean values reduce in a time-dependent manner between 7% to 8% at about 2 hours and 15% to 21% at about 4 hours compared with liver SUL mean value at about 1 hour uptake time. Similar to our prior study of early scans (uptake time about an hour), we have demonstrated excellent interreader agreement in delayed scans, regardless of the site of VOI placement within the right lobe of the liver. The significance of these results is that there is very small variability or change in liver SUL mean between 1-hour and 2-hour uptake time, which are the most relevant uptake time for clinical studies as most of the studies would be performed in this time interval. Because we use liver SUL mean for quality control and, sometimes, for deciding threshold for including index lesions for therapy assessment or measuring metabolic tumor volume or total lesion glycolysis of tumors, the magnitude of liver SUL mean reduction is important, especially with prolonged uptake time greater than 50 to 70 minutes. In some studies with dual-point FDG PET/CT, liver SUV was used as control, and the VOI was marked in the right lobe of the liver. 16, 20, 24, 25 Koyama et al 26 suggested stable or slightly decreased ratio of FDG uptake in the hepatic parenchyma to other soft tissues from early to delayed scans. However, independent hepatic parenchyma activity was not evaluated. Kubota et al 14 showed that the SUV max changes in normal liver were significantly decreased from early to delayed images. Similar results were seen in the study by Nishiyama et al. 16 Both of these studies investigated the changes in liver SUV max between early and delayed images. Nishiyama et al 24, 25 in their latter studies showed that SUV mean tends to be significantly lower in delayed scans compared with the early scans (P G 0.0001). However, recent studies by Kubota et al 27 and Chin et al 28 showed that there is no significant variability of the liver SUV mean between early and delayed images in 2 different and independent set of patients. However, these authors did not perform direct comparison of the early and the delayed image of the same patients, unlike in our study.
Our previous study 5 has shown that liver SUL mean values measured at 3 different levels of the right lobe of the liver in early images have almost perfect interreader agreement with the highest precision in the upper aspect of the right lobe of the liver. The results in this study indicate that there is excellent interreader agreement in liver SUL mean both in early and delayed images. Other studies also have shown that SUV measurements have excellent interreader reproducibility. 29 The reliability and variability of the liver SUL mean are consistent 30Y32 with other studies.
Our study results need to be interpreted in the context of our study design. We used 2 sets of patients, pancreatic cancer and NF patients, for whom we routinely do 2-hour and 4-hour delayed imaging in our clinical practice. Our study population is moderate size for early and delayed imaging studies and small at 4-hour delayed imaging. However, the advantage of this study population is that both early and delayed images were done in the same patients, minimizing the impact of covariates. For the interreader component of the study, we used 1 software, MIMvista software, and we need to test the interreader agreement and variability using multiple vendor software systems for quantitative imaging.
In conclusion, there is a very small change about 7% to 8% in liver SUL mean for most uptake times relevant to clinical FDG PET/CT scans. Therefore, liver SUL mean could represent a useful reference parameter in quantitative analysis of dual-phase FDG PET/CT in malignancy or atypical infection/inflammatory disease. There is very good interreader agreement when liver SUL mean is measured at 3 different levels of the right lobe of the liver in delayed scans with uptake time greater than 1 hour. Hence, liver SUL mean is a reliable parameter for quality control and threshold setting for background FDG uptake and tumor volume segmentations in FDG PET/CT scans in clinical practice. Furthermore, it may be suitable as normalization factor in currently available formulae quantifying therapy response on PET imaging.
